Safety of Growth Hormone Treatment
Journal Title: Journal of Clinical Research in Pediatric Endocrinology - Year 2009, Vol 1, Issue 1
Abstract
Growth hormone (GH) is being used in the treatment of GH deficiency and in the treatment of other conditions with increasing frequency. Several uncommon potentially adverse events including idiopathic intracranial hypertension (IIH), slipped capital femoral epiphysis (SCFE), increase in the number of pigmented nevi, gynecomastia, scoliosis, insulin resistance and a possible increase in malignancy have been associated with GH treatment. Despite its potential adverse effects, GH has had a good safety record up to now. This review will focus on the potential side effects of GH treatment in GH and non-GH deficient conditions. DOI: 10.4008/jcrpe.v1i1.8
Authors and Affiliations
Feyza Darendeliler
Keywords
Related Articles
- EP ID EP129095
- DOI -
- Views 112
- Downloads 0
The Relationship Between Leptin and Norepinephrine Levels During OGTT in Normotensive and Hypertensive Obese Adolescents <br />
Background/Aims: Studies in adult population have suggested that leptin might play a role in inducing obesity related hypertension mediated by the sympathetic nervous system. This association has not been established for...
The relationship between serum ghrelin levels and hair zinc concentrations in children
Background: Zinc (Zn) plays a central role in the activation of numerous enzyme systems that synthesize and degrade bioactive peptides. Some of these bioactive peptides, also called neuropeptides, are involved in the reg...
Obesity in Childhood: definition and epidemiology
Obesity is defined as a condition where a pathological excess of body fat is present in an individual. Obesity develops when there is a discrepancy between energy intake and energy output. During its development the orig...
A Patient with 22q11.2 Deletion Syndrome: case report
22q11 deletion is one of the most frequently encountered genetic syndromes. The phenotypic spectrum shows a wide variability. We report a boy who presented at age 11.9 years with seizures due to hypocalcemia as a result...
Hypophosphatasia Presenting with Pyridoxine-Responsive Seizures, Hypercalcemia, and Pseudotumor Cerebri: Case Report
Hypophosphatasia (HPP) is an inborn error of metabolism characterized by defective bone mineralization caused by a deficiency in alkaline phosphatase (ALP) activity due to mutations in the tissue-nonspecific ALP (TNALP)...